The effect of COVID-19 on oncology practice in Turkey
1Eskisehir City Hospital, Department of Medical Oncology 71 Evler Mahallesi, Cavdarlar SK. , 26080 Odunpazarı/Eskisehir Evler Mah, Turkey.
Purpose:
The novel coronavirus (COVID-19) was defined in China, leading an outbreak, impacted the organization, and maintained cancer care. Although the alterations of cancer treatment maintenance were evaluated, the difference in physicians' side was not determined. In this survey study, we tried to assess the alteration of Turkish oncologists' daily practice.
Methods:
An online survey was prepared via Google forms and sent to oncologists registered to the Turkish Society of Medical Oncology. One hundred twenty-eight oncologists answered the online survey.
Results:
Twenty-three percent of the oncologists moved their facilities to another place in the hospital after the pandemic, which was resulted in nearly 90% of worse patient services. Seventy percent of the oncologists did not receive any duties on COVID-19 services after Turkey's first case. Thirty-one percent of the oncologists stated their oncology practice was disturbed by working in the COVID-19 services. Three oncologists accepted they were responsible for cross-infection to oncology patients. Eighty-five percent of the oncologists declared oncology practice was disturbed by the other specialists' assignment in COVID-19 services. The leading areas were general surgery, pulmonary diseases, and ENT, according to oncologists. Twenty-two percent of the oncologists needed to send their patients to other oncology clinics due to the COVID-19 pandemic.
Conclusion:
Although oncologists tolerated oncological patient management alterations, the prolonged pandemic situation may harm oncology practice via the loss of oncologists' motivation and incomplete multi-disciplinary patient management. There is a need for follow-up studies to evaluate the situation for the alternation in the COVID-19 pandemic..
Insights
Turkish oncologists faced significant practice disruptions due to the COVID-19 pandemic, impacting cancer care delivery and physician motivation. Further studies are needed to address these challenges in oncology practice.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic significantly impacted global healthcare systems, including cancer care.
- While changes in cancer treatment were assessed, the impact on physicians, particularly oncologists, remained unclear.
Purpose of the Study:
- To evaluate the alterations in the daily practice of Turkish oncologists during the COVID-19 pandemic.
- To understand the challenges faced by oncologists in maintaining cancer care amidst the pandemic.
Main Methods:
- An online survey was distributed to oncologists registered with the Turkish Society of Medical Oncology.
- Data was collected from 128 participating oncologists.
Main Results:
- 23% of oncologists relocated facilities, leading to ~90% worse patient services.
- 31% reported practice disturbances due to COVID-19 service duties, with 85% affected by other specialists' involvement.
- 22% referred patients to other clinics, highlighting care fragmentation.
Conclusions:
- Oncologists adapted to practice changes, but prolonged pandemic may decrease motivation and hinder multidisciplinary care.
- There is a need for follow-up research to assess the long-term effects on oncology practice and patient management.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Tumor Immunotherapy
Treatment Resistant Cancers
Therapeutic Drug Monitoring: Affecting Factors
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
